Pomegranate extract specifically inhibits Clostridium difficile growth and toxin production without disturbing the beneficial bacteria in vitro
Open Access
- 1 November 2018
- journal article
- research article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 11, 2357-2362
Abstract
Objective: The aim of this study was to assess the pomegranate juice against the growth and toxin production of multidrug-resistant Clostridium difficile hypervirulent strain NAP1/027/BI and also against the growth of beneficial bacteria to prevent or suppress C. difficile infection (CDI). Materials and methods: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were taken as parameters for the assessment of antimicrobial property of the pomegranate juice. Four different C. difficile hypervirulent strains NAP1/027/BI, Lactococcus lactis spp., Lactobacillus casei, and Bifidobacterium animalis were subjected to the broth dilution method to determine the MIC and MBC. Enzyme-linked immunosorbent assay (ELISA) was performed to determine clostridial toxin B (TcdB) production in the presence of pomegranate juice. Results: The MIC and MBC of pomegranate juice containing punicalagin were found to be 390 µg/mL for all C. difficile hypervirulent strain NAP1/027/BI, and the growth of L. lactis spp., L. casei, and B. animalis was not inhibited. Pomegranate juice reduced TcdB production in C. difficile hypervirulent strain NAP1/027/BI. Conclusion: This study highlights the potential of pomegranate juice to reduce CDI without affecting the beneficial bacteria. Pomegranate juice may be a useful antimicrobial agent to prevent or suppress CDI, avoiding the use of antibiotics.Keywords
This publication has 31 references indexed in Scilit:
- Pomegranate ellagitannins stimulate growth of gut bacteria in vitro: Implications for prebiotic and metabolic effectsAnaerobe, 2015
- Pomegranate extract exhibits in vitro activity against Clostridium difficileNutrition, 2014
- Benefits of polyphenols on gut microbiota and implications in human healthThe Journal of Nutritional Biochemistry, 2013
- Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidenceInternational Journal of Antimicrobial Agents, 2012
- Plant extracts for the control of bacterial growth: Efficacy, stability and safety issues for food applicationInternational Journal of Food Microbiology, 2012
- The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiotaInternational Journal of Food Microbiology, 2010
- The Effect of Pomegranate (Punica granatumL.) Byproducts and Ellagitannins on the Growth of Human Gut BacteriaJournal of Agricultural and Food Chemistry, 2009
- Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatantsAnaerobe, 2006
- Characterization of quercetin binding site on DNA gyraseBiochemical and Biophysical Research Communications, 2003
- Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and ProcessingJournal of Agricultural and Food Chemistry, 2000